Holen Sie sich die Stockscreener-App
6.61
63.21%
2.56
Handel nachbörslich:
6.70
0.09
+1.36%
Schlusskurs vom Vortag:
$4.05
Offen:
$5.22
24-Stunden-Volumen:
9.98M
Relative Volume:
32.57
Marktkapitalisierung:
$44.52M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-126.61M
KGV:
-3.3724
EPS:
-1.96
Netto-Cashflow:
$-60.14M
1W Leistung:
+54.44%
1M Leistung:
+71.07%
6M Leistung:
-2.79%
1J Leistung:
-73.87%
1-Tages-Spanne:
$5.15
$6.95
1-Wochen-Bereich:
$3.96
$6.95
52-Wochen-Spanne:
$3.004
$29.40
Generation Bio Co Stock (GBIO) Company Profile
Firmenname
Generation Bio Co
Sektor
Branche
Telefon
857-529-5908
Adresse
301 BINNEY STREET, CAMBRIDGE
Vergleichen Sie GBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GBIO
Generation Bio Co
|
6.61 | 27.14M | 0 | -126.61M | -60.14M | -1.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Generation Bio Co Stock (GBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-10-19 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2022-11-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-12-14 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-06-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-02-24 | Eingeleitet | William Blair | Outperform |
| 2021-02-18 | Eingeleitet | Needham | Buy |
| 2020-07-07 | Eingeleitet | Cowen | Outperform |
| 2020-07-07 | Eingeleitet | JP Morgan | Overweight |
| 2020-07-07 | Eingeleitet | Jefferies | Buy |
| 2020-07-07 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Generation Bio Co Aktie (GBIO) Neueste Nachrichten
Generation Bio Shares Surge Following Restructuring Plans, Q2 Results - MarketScreener
Generation Bio soars as it explores strategic alternatives - Seeking Alpha
How to escape a deep drawdown in Generation Bio Co.2025 Market WrapUp & Precise Buy Zone Identification - Newser
Why Generation Bio Co. stock attracts strong analyst attentionJuly 2025 Movers & Intraday High Probability Setup Alerts - thegnnews.com
Generation Bio Co. stock prediction for this weekJuly 2025 Update & Low Drawdown Trading Techniques - Newser
Wedbush downgrades Generation Bio stock rating to Neutral amid restructuring By Investing.com - Investing.com South Africa
Wedbush downgrades Generation Bio stock rating to Neutral amid restructuring - Investing.com
Generation Bio Stock Surged 31% Pre-Market Today – What’s Going On? - Stocktwits
Wedbush Downgrades Generation Bio to Neutral From Outperform, Price Target is $7 - MarketScreener
Jefferies lowers Generation Bio stock price target to $12 from $40 - Investing.com Nigeria
Visual trend scoring systems applied to Generation Bio Co.July 2025 Reactions & Free High Accuracy Swing Entry Alerts - Newser
Published on: 2025-08-13 00:40:37 - Newser
Visual analytics tools that track Generation Bio Co. performancePortfolio Profit Report & Expert Verified Stock Movement Alerts - Newser
What institutional flow reveals about Generation Bio Co.Smart Chart Forecasting with AI Algorithms - Newser
Generation Bio Reports Q2 Revenue Drop of 81%, Announces 90% Workforce Reduction and Strategic Review - AInvest
What recovery options are there for Generation Bio Co.Market Risk Report & Daily Stock Momentum Reports - Newser
Will Generation Bio Co. bounce back from current supportIntraday Price Action Forecast Planner - Newser
Generation Bio Co. (GBIO) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Generation Bio Co reports results for the quarter ended June 30Earnings Summary - TradingView
Generation Bio to cut 90% of workforce amid strategic review - Investing.com
Generation Bio's T Cell Delivery Success Leads to Strategic Review as Company Cuts 90% of Workforce - Stock Titan
Using AI based signals to follow Generation Bio Co.Free Trend Analysis for Safer Trades - Newser
Using fundamentals and technicals on Generation Bio Co.Weekly Outlook for Short Term Investors - Newser
Institutional scanner results for Generation Bio Co.Smart Money Strategy for Growth Stocks - Newser
Published on: 2025-08-11 23:12:12 - Newser
Published on: 2025-08-11 21:13:44 - Newser
Long term hold vs stop loss in Generation Bio Co.Free Step-by-Step Stock Investment Guide - Newser
Generation Bio Co. recovery potential after sell offSwing Trade Entry and Exit Point Analysis - Newser
Should you hold or exit Generation Bio Co. nowTrend Confirmation Scanner with Entry Focus - Newser
Measuring Generation Bio Co.’s beta against major indicesRisk Balanced Picks for Safer Trading - Newser
How to interpret RSI for Generation Bio Co. stockWeekly Market Direction and Sector Summary - Newser
Forecasting Generation Bio Co. price range with options dataDaily Technical Chart Pattern Analysis Report - Newser
Can Generation Bio Co. Rally Enough to Break EvenDay Trading Signals With High Precision Reviewed - beatles.ru
What momentum shifts mean for Generation Bio Co.Trade Plan With Low Risk High Return - Newser
Finanzdaten der Generation Bio Co-Aktie (GBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):